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The p53 tumor suppressor utilizes multiple mecha-
nisms to selectively regulate its myriad target genes,
which in turn mediate diverse cellular processes.
Here, using conventional and single-molecule
mRNA analyses, we demonstrate that the nucleo-
porin Nup98 is required for full expression of p21,
a key effector of the p53 pathway, but not several
other p53 target genes. Nup98 regulates p21 mRNA
levels by a posttranscriptional mechanism in which
a complex containing Nup98 and the p21 mRNA
30UTR protects p21 mRNA from degradation by
the exosome. An in silico approach revealed another
p53 target (14-3-3s) to be similarly regulated by
Nup98. The expression of Nup98 is reduced in
murine and human hepatocellular carcinomas
(HCCs) and correlates with p21 expression in HCC
patients. Our study elucidates a previously unrecog-
nized function of wild-type Nup98 in regulating
select p53 target genes that is distinct from the
well-characterized oncogenic properties of Nup98
fusion proteins.
INTRODUCTION
The p53 tumor suppressor functions as a sequence-specific
transcriptional regulator for a great variety of target genes.
Different subsets of these target genes mediate various cellular
outcomes such as cell-cycle arrest, senescence, programmed
cell death, or others (reviewed in Vousden and Prives, 2009).
The underlying molecular processes that dictate p53 target
gene preference are complex and still only partially understood.
Previously we found that the nuclear transport factor hCAS/
Cse1L binds to a subset of p53 target gene promoters and is
required for their full activation upon stress-mediated p53 induc-
tion (Tanaka et al., 2007).
An RNAi screen against other nuclear transport factors,
nuclear pore components in particular, suggested that the
nucleoporin Nup98may also contribute to target gene selectivity
of p53. Nucleoporins (Nups), essential components of the
nuclear transport machinery, form the nuclear pore complex
(NPC), which is embedded in the nuclear envelope and facilitates
nucleocytoplasmic trafficking (reviewed in D’Angelo and Hetzer,
2008). An increasing body of evidence (largely from studies in
yeast) suggests that in addition to their well-characterized role
in transport, some Nups are also involved in regulating gene
expression (reviewed in Ko¨hler and Hurt, 2010; Strambio-De-
Castillia et al., 2010). In particular, Nup98, a major component
of the NPC (Cronshaw et al., 2002), was reported to move from
the NPC into the nucleoplasm in a transcription-dependent
manner (Griffis et al., 2002) and also to be involved in mRNA
export (Enninga et al., 2002; Powers et al., 1997), Further,
Drosophila Nup98 is required for activation of genes related to
stress response, cell-cycle progression, and development
(Capelson et al., 2010; Kalverda et al., 2010). Nup98 has also
been linked to cancer, yet only within the context of Nup98
oncogenic fusion proteins that occur as a consequence of
Molecular Cell 48, 799–810, December 14, 2012 ª2012 Elsevier Inc. 799
chromosomal translocations in leukemias (e.g., Nup98-HOXA9
t[7;11][p15;p15]; Moore et al., 2007; reviewed in Xu and Powers,
2009)). The function of wild-type Nup98 in tumor development is
largely unknown.
RESULTS
Nup98 Ablation Selectively Reduces p21 mRNA
and Protein Accumulation upon p53 Activation
Since a Nup siRNA screen identified Nup98 as a likely determi-
nant of p53 target gene selectivity (see Figure S1A online), we
transfected HepG2 liver cancer cells (wild-type p53) with
Nup98 siRNAs and then treated the cells with Camptothecin
(CPT) to activate p53. The induction of p53 target gene
mRNAs including p21 (=CDKN1A), PUMA, GADD45, NOXA,
and ATF3 was measured by quantitative real-time PCR
(qRT-PCR) (Figure 1A). p21 mRNA (Figure 1A) or protein (Fig-
ure 1B) was unique in being affected by Nup98 ablation.
A
B C
Figure 1. Nup98 Depletion Selectively
Reduces p21 mRNA and Protein Accumula-
tion upon p53 Activation
(A) HepG2 cells were treated either with control (ctrl)
or two Nup98 siRNAs (Nup98#1 and Nup98#2) for
72 hr, and CPT (300 nM) was added for the final
24 hr before lysis of cells for mRNA and protein
analysis. Relative expression of p53 target genes
p21, PUMA, GADD45, NOXA, ATF3, and Nup98
was measured by qRT-PCR and normalized to 1 for
each ctrl siRNA and drug treatment condition. Data
are presented as mean ± standard deviation (SD) of
three independent experiments.
(B) HepG2 cell were treated as in (A), and cell
extracts were examined by immunoblotting with
indicated antibodies.
(C) HepG2 cells were treated either with control
(ctrl) or Nup98#1 and Nup98#2 siRNA for 72 hr, and
Nutlin-3 (20 mM) was added 24 hr prior to extraction
of cells for protein analysis. Cell extracts were
analyzed by immunoblotting with the indicated
antibodies.
Similar results were obtained in HepG2
cells treated with Daunorubicin (data not
shown) as well as in Huh-6 and Sk-
Hep1 cells treated with CPT (Figure S1B).
Nup98 knockdown also led to decreased
p21 (but not PUMA) protein upon treat-
ment with Nutlin, a compound that
disrupts the p53-Mdm2 complex. This
indicates that the effects of Nup98
depletion were independent of DNA
damage signaling (Figure 1C). Further,
Nup98 depletion selectively reduced
p21 mRNA induction in Hep3B-4Bv cells
that harbor a temperature-sensitive p53-
mutant (Friedman et al., 1997) at 32C
when p53 is in wild-type conformation
(Figure S1C). The basal levels of p21
mRNA in the presence or absence of Nup98 were largely
unchanged in three different liver cancer cell lines, suggesting
that only induced p21 expression (here in response to upregu-
lated levels of p53) relies on full expression of Nup98 (Fig-
ure S1D). Taken together, our data suggest that Nup98 is
required for induction of p21 by p53 in a DNA damage-inde-
pendent manner.
The predominant biogenesis of Nup98 occurs by autocleav-
age of a Nup98/Nup96 precursor protein (Fontoura et al.,
1999; Rosenblum and Blobel, 1999). Arguing strongly against
the possibility that Nup96 is also involved in p21 expression, is
the finding that, upon transfection of two Nup98 siRNAs, despite
decreased amounts of precursor Nup98/96 mRNA, Nup96
protein levels remained unaltered (Figure S1E, left panels, top
and bottom; see right panel for Nup96 antibody specificity).
Having excluded Nup96 as a factor in controlling p21 gene
expression, we went on to examine the mode by which Nup98
regulates p21 mRNA accumulation.
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Nup98 Regulates p21 by a Posttranscriptional
Mechanism
To determine the stage of p21 gene expression that is regulated
by Nup98, we compared induction of nascent unspliced and
mature spliced p21 mRNA in HepG2 cells, using primers that
anneal to intronic regions of unspliced p21 mRNA (first and
second intron, respectively) or exon-spanning primers that
detect only spliced, mature p21 mRNA (Figure 2A, upper left
panel). Interestingly, while induction of nascent p21 mRNA
(upon CPT treatment) was not significantly impacted by Nup98
knockdown (Figure 2A, upper right and lower left panels), levels
of mature p21 mRNA were significantly decreased upon Nup98
depletion compared to the control siRNA-treated cells (Fig-
ure 2A, lower right panel).
To confirm that the lowered p21 mRNA levels upon Nup98
knockdown were independent of transcription initiation, and
also to exclude a splicing defect, we utilized an H1299 derivative
p53 null cell line (H24-p21) in which p21 mRNA is transcribed
from a p21 cDNA construct under the control of an artificial
‘‘tet-off’’ promoter (Niculescu et al., 1998). This construct lacks
intronic regions but does contain part of the p21 30UTR. In these
cells, Nup98 knockdown again resulted in impaired accumula-
tion of p21 mRNA (Figure 2B, left panel) and protein (Figure 2B,
right panel). As before, Nup96 protein levels were unaltered by
Nup98 siRNAs (Nup98#1 and Nup98#2) despite a decrease in
the Nup98/Nup96 precursor mRNA (Figure S2A). In a related
H1299 cell derivative, inducible ectopic PUMA expression was




Figure 2. Posttranscriptional Regulation of
p21 by Nup98
(A) Nup98 regulates the levels of mature but not
nascent p21 mRNA. (Upper left panel) Schematic
depicts primers used to amplify different regions
of nascent and mature p21 mRNA. The numbers
indicate the position of the amplicon within the
p21 gene locus. Rectangles represent exons 1–3.
HepG2 cells were treated as described in Fig-
ure 1A. Nascent p21 mRNA induction was
measured by qRT-PCR with primer pairs anneal-
ing to intronic regions of the unspliced transcript:
first intron (+4001) (upper right panel) and second
intron (+7011) (lower left panel), respectively.
(Lower right panel) Spliced p21 mRNA was
measured by using the exon-spanning primer pair
(+5817/+7223) indicated in the schematic. Data
are presented as mean ± SD of two independent
experiments.
(B) Nup98 regulates exogenous p21 mRNA. (Left
panel) H24-p21 cells containing a tetracycline
(Tet-off)-regulatable p21 expression construct
were treated either with control (ctrl) or Nup98
siRNAs (Nup98#1 and Nup98#2) for 72 hr as in
Figure 1. p21 was induced by removal of Tet 24 hr
before harvesting. Left panel shows relative p21
and Nup98 mRNA expression measured by qRT-
PCR and normalized to 1 for the ‘‘ctrl siRNA tet-’’
condition. Data are presented as mean ± SD
derived from two independent experiments. (Right
panel) Protein expression from the same experi-
mental condition analyzed by immunoblotting with
indicated antibodies.
(C) PUMA levels are not affected by Nup98
knock-down. H1299-derivative cell line containing
a tetracycline (Tet-on)-regulatable PUMA expres-
sion construct (H24-PUMA) was treated either with
control (ctrl) or two Nup98 siRNAs (Nup98#1 and
Nup98#2) for 72 hr. PUMA was induced by adding
Doxycycline 24 hr before harvesting. Cell extracts
were analyzed by immunoblotting with indicated
antibodies.
(D) Nup98 stabilizes mature p21 mRNA. HepG2
cells were treated either with control (ctrl) or
Nup98#2 siRNA (Nup98#2) for 72 hr, and Nutlin-3
(20 mM) was added 24 hr before blocking
mRNA synthesis with 0.4 mM Actinomycin D
(Act-D). Cells were harvested at indicated time points, and mature p21 mRNA decay was measured by qRT-PCR with the exon-spanning primer pairs described
in Figure 2A. The solid and dotted lines indicate the half-life of p21 in ctrl-siRNA or Nup98#2 conditions, respectively.
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Based on these findings, we hypothesized that Nup98
stabilizes mature p21 mRNA. To test this, we performed
mRNA half-life experiments by blocking transcription with Acti-
nomycin D in the presence or absence of Nup98 siRNAs.
As predicted, p21 mRNA induced by either Nutlin (Figure 2D)
or CPT (Figure S2B) treatment in HepG2 cells had a shorter
half-life (approximately 45 min) when Nup98 was ablated
by siRNA (siNup98#2) compared to the control condition
(approximately 90 min). Similar findings were obtained with
another Nup98 siRNA (Figure S2C). Consistent with the observa-
tion that uninduced p21 mRNA levels do not change in
response to Nup98 ablation in HepG2 cells, we did not observe
differences in basal p21 mRNA half-life under these conditions
(Figure S2D).
Taken together, Nup98-mediated regulation of p21 mRNA
occurs by a splicing-independent posttranscriptional mecha-
nism that involves stabilization of the mature p21 mRNA
transcript.
Decreased p21 mRNA Accumulation upon Nup98
Knockdown Occurs in the Nucleus and the Cytoplasm
and Can Be Rescued by Blocking the Exosome
Our results indicated that Nup98 knockdown is associated with
a higher rate of p21 mRNA turnover. Since mRNA degradation
can occur at each step from the site of transcription to the site
of translation (reviewed in Houseley and Tollervey, 2009), we
sought to determine in which cellular compartment Nup98
affected p21 mRNA stability. Furthermore, since Nup98 is re-
ported to be involved in mRNA export (Enninga et al., 2002),
we wanted to address whether or not Nup98 knockdown leads
to nuclear p21 mRNA accumulation. We used single-molecule
sensitive fluorescence in situ hybridization (mRNA FISH) (Femino
et al., 1998) to obtain a detailed and quantitative view of nuclear
and cytoplasmic p21mRNAmolecules before and after p53 acti-
vation in the presence or absence of Nup98. As expected, Nutlin
treatment caused an increase in the overall number of single p21
mRNA transcripts in HepG2 cells (Figures 3A and 3B and
summarized in Table S1), which was significantly decreased
upon Nup98 knockdown (Figures 3C and 3D and Table S1).
Nup98 depletion led to a marked reduction in cytoplasmic and
more modest diminution of nuclear p21 mRNA molecules in
Nutlin-treated cells (Figures 3C and 3D and Table S1). As an
additional control, in cells containing p21 siRNA, even fewer
cytoplasmic p21 mRNA molecules were detected (Figure 3E
and Table S1). Although p21 mRNA did not accumulate in the
nucleus upon Nup98 depletion (but actually decreased), a role
for Nup98 in p21 mRNA export remains plausible (see the
Discussion).
mRNA degradation in yeast strains with mutated Nup116
(a homolog of mammalian Nup98) is mediated by the exosome
(Das et al., 2003). We therefore determined whether the reduced
levels of p21 mRNA could be rescued by codepletion of Exosc3
(Rrp40), a core component of the exosome. As shown in Fig-
ure 3F, codepletion of Exosc3 with Nup98 in the H24-p21 cell
line prevented the decrease of p21 mRNA levels observed after
Nup98 knockdown alone. These results implicate a role of
Nup98 in stabilizing p21 mRNA transcripts in a manner that
precludes their turnover by the exosome.
The 30UTR of p21 mRNA Associates with Nup98
and Is Required for Nup98-Mediated Increased
p21 mRNA Levels
Nup98 localizes primarily at the NPC, reflected in a punctate
nuclear rim staining, and to a minor extent within the nucleus,
detected as intranuclear foci previously described as GLFG
bodies (Enninga et al., 2002; Griffis et al., 2002; and Figure S3A).
We hypothesized that Nup98 may associate with p21 mRNA
and thereby affect its stability in the nucleus (and the cytoplasm
as well). To address this, RNA-IP experiments were performed
in which Nup98 was immunoprecipitated from formaldehyde
crosslinked samples of HepG2 cells that were untreated
or CPT treated (Figure 4A) or treated with Nutlin (data not
shown). For amplification by qRT-PCR, primer pairs specific
for different regions of p21 mRNA or PUMA mRNA (as a
negative control) were used to localize the potential regions of
interaction with Nup98 (or Nup98-associated protein). Remark-
ably, Nup98 could be coimmunoprecipitated with p21 mRNA,
with the most significant interaction being detected in the
30UTR. By contrast, an anti-Nup98 RNA-IP revealed almost
no interaction within the PUMA 30UTR. Nup98 also coimmuno-
precipitated with p21 mRNA in H24 p21 tet-off cells, again
with the strongest interaction being detected in the 30UTR
(Figure S3B).
These results were extended by experiments showing that
ectopic Nup98 was able to significantly increase the levels of
coexpressed full-length p21 cDNA (p21 FL) but not p21 cDNA
lacking the 30UTR (p21 del 30UTR) (Figure 4B; see Figure S3C
for corresponding protein levels). Approximately 10-fold more
transfected p21 FL construct than p21 del 30UTR construct
was required to reach equivalent p21 mRNA levels, suggesting
that the p21 30UTR per se is a negative regulator of p21 mRNA
stability. We also observed that the p21 30UTR fused to the
coding DNA sequence (CDS) of Luciferase (Luc/p21 30UTR)
mediates a similar response to Nup98 (Figure 4C). Finally,
Nup98 overexpression led to an increase of a hybrid construct
(CDS of PUMA attached to the 30UTR of p21; Pu/p21), while
full-length Puma 30UTR (Pu FL) was unaffected (Figure 4D).
Taken together, our data show that the p21 30UTR is necessary
and sufficient for the ability of Nup98 to augment the accumula-
tion of p21 mRNA.
Two domains of Nup98 have been implicated for its role in
mRNA export. One is the glycine-leucine-phenylalanine-glycine
(GLFG) repeat domain that is important for transcription-
dependent mobility of Nup98 and which serves as a docking
site for the mRNA export receptor TAP/NXF1 (Blevins et al.,
2003; Griffis et al., 2004). The other is the Gle-2-binding domain
(GBD) mediating the interaction of Nup98 with the mRNA export
factor Rae1/Gle2 that also interacts with TAP (Blevins et al.,
2003). Different truncated versions of Nup98 were expressed in
H1299 cells along with cotransfected p21 (p21 FL). Overexpres-
sion of full-length Nup98 (construct #1) maximally increased
p21 protein expression in a concentration-dependent manner,
whereas the C terminus alone (construct #2; 506–920) only
produced a modest increase (Figure 4E). Overexpression of
the full-length GLFG repeat domain plus the C terminus
(construct #3; 221–920) but lacking the GBD was sufficient to
increase p21 protein to levels seen with wild-type Nup98. The
Molecular Cell
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Figure 3. Nup98 Affects Nuclear and Cytoplasmic p21 mRNA Level and Protects p21 mRNA from Degradation by the Exosome
Nup98 knockdown affects the levels of nuclear and cytoplasmic p21 mRNA.
(A–E) Left panels show images of HepG2 cells that were treated either with ctrl (A and B) or Nup98#1 (C) Nup98#3 (D) or p21 (E) siRNAs for 72 hr and then treated
with either DMSO (A) or Nutlin-3 (20 mM; B–E) for 24 hr prior to single-mRNA FISH analysis as described in the Experimental Procedures. FISH images were
detected in theCy5 channels and color coded as red. The blue channel contains aDAPI stain to demarcate the nuclei. For display, 5–15 images, depending on cell
shape, from the cell midsection were averaged in both channels. Scale bar shown in (E) equals 2 mm in all images. Right panels are histograms of p21 mRNA
molecule counts per cell corresponding to (A) (48 cells counted), (B) (58 cells counted), (C) (29 cells counted), (D) (55 cells counted), and (E) (59 cells counted). Data
are pooled from three repeats of the experiments with errors and statistical analysis shown in Table S1.
(F) Exosc3 knockdown rescues lowered p21 mRNA levels upon Nup98 depletion. H24 p21 tet-off cells were treated individually with either control (ctrl) or
Nup98#1 siRNA, or cotransfected with Exosc3 siRNA (Ex3#1 and Ex3#2) for 72 hr as indicated. p21 was induced by removal of Tet 48 hr before harvesting.
Relative p21mRNA levels were measured with qRT-PCR. Data are presented as mean ± SD (left panel). Western blot (inset) shows Exosc3 levels in p21 H24 cells
treated either with ctrl or Ex3#1 and Ex3#2 siRNA. Actin serves as loading control.
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C-terminal half of the GLFG repeat domain plus the C terminus
(construct #4; 362–920) was not able to fully stabilize p21.
Thus the intact GLFG repeat but not the GBD of Nup98 is
necessary for full stabilization of p21. Nup98-dependent regula-
tion of p21 may require the mobility of Nup98 and/or its interac-
tion with TAP but is independent of its interaction with Rae1/
Gle2. In line with this, in our siRNA screen the depletion of
Rae1/Gle2 did not lead to reduced p21 mRNA accumulation
(Figure S1A).
An In Silico Approach Identifies 14-3-3s as Another
p53 Target Gene mRNA that Is Bound and Regulated
by Nup98
Since the strongest association of Nup98with p21mRNA occurs
in its 30UTR, we sought to determine whether other mRNAs
within the p53 transcriptional regulon might also be regulated
posttranscriptionally by Nup98 (Keene, 2007). We adapted
a computational method previously used to infer mechanisms




Figure 4. The 30UTR of p21 mRNA Coasso-
ciates with Nup98 and Is Required for
Nup98-Mediated Increased Levels of p21
mRNA
(A) Nup98 associates with the 30UTR of p21. RNA-
IP was performed as described in the Experi-
mental Procedures. Briefly, Nup98 was immuno-
precipitated from 0.1% formaldehyde crosslinked
samples of CPT (300 nM for 24 hr)-treated or
untreated HepG2 cells. Coimmunoprecipitated
mRNAs crosslinked to Nup98 were reverse tran-
scribed and amplified by qRT-PCR. Primer pairs
specific for different regions of p21 mRNA or
PUMA mRNA were used. In the schematic below,
the graph rectangles represent exonic regions of
the respective genes, and shaded rectangles
indicate the 30UTRs of p21 and PUMA mRNA as
indicated. The numbers below the lines indicate
the position of each amplicon within the p21 or
PUMA gene locus, respectively. Data are pre-
sented as mean ± SD.
(B) The 30UTR of p21 mRNA is required for
increased p21 expression levels mediated by
ectopically expressed Nup98. Hep3B cells were
cotransfected with HA-tagged Nup98 (0.75 or
1.25 mg) and p21 cDNA containing the 30UTR (p21
FL, 200 ng) or p21 cDNA without the 30UTR (p21
del 30UTR, 20 ng) 24 hr prior to RNA extraction.
p21 mRNA levels transcribed from the respective
constructs were measured with qRT-PCR. Data
are presented as mean ± SD.
(C) The 30UTR of p21mRNA is sufficient for stabi-
lization by Nup98. H1299 cells were cotransfected
with HA-tagged Nup98 (1.75 mg) and a Luciferase
construct (Luc/p21 30UTR, 200 ng) containing the
30UTR of p21 mRNA or the Luciferase construct
lacking the p21 mRNA 30UTR (Luc ctrl, 20 ng) 48 hr
prior to RNA extraction. The mRNA levels tran-
scribed from the respective constructs were
measured with qRT-PCR. Data are presented as
mean ± SD of two independent experiments.
(D) The 30UTR of p21mRNA is sufficient for stabi-
lization by Nup98. H1299 cells were cotransfected
with HA-tagged Nup98 (1.75 mg) and a construct
containing the coding DNA sequence (CDS) and
the 30UTR of PUMA (Pu FL, 200 ng) or a hybrid
construct containing the PUMA CDS fused to the
30UTR of p21 (Pu/p21, 200 ng) The mRNA levels
transcribed from the respective constructs were
measured with qRT-PCR. Data are presented as
mean ± SD.
(E) The GLFG repeat domain of Nup98 is required for maximal increase of p21 expression. H1299 cells were cotransfected with GFP-tagged full-length (#1) or
truncated (#2–#4) Nup98 constructs with indicated concentrations and 1 mg untagged full-length p21 cDNA 24 hr before protein extraction. Immunoblot shows
protein expression of transfected Nup98 and p21 detected with the indicated antibodies. Actin serves as loading control.
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genome-wide changes in steady-state transcript abundance
in yeast (Foat et al., 2005). The REDUCE software suite (see
Figure 5A and the Experimental Procedures) was used to
discover RNA sequence motifs whose occurrence in 30UTRs
is predictive of the difference in gene expression 72 hr after
doxorubicin treatment, i.e., between cells in which p53 is active
versus inactive (Chau et al., 2009). This yielded a single, highly
significant C-rich motif (Figure 5A), occurrences of which in
the 30UTR are predictive of mRNA stabilization upon p53 activa-
tion (p value = 5 3 1026). To determine whether the motif
indicates a potential mRNA or genomic DNA binding element,
we analyzed how the correlation with differential gene expres-
sion differed when counting motif occurrences in 400 nt
windows immediately upstream or downstream of polyadenyla-
tion sites in genomic DNA (Figure 5B). The correlation was
significantly higher for the upstream window, suggesting that





Figure 5. An In Silico Approach Identifies
14-3-3s as Another p53 Target Gene
mRNA that Associates with and Is Regu-
lated by Nup98
(A) Flow chart describing the unbiased genome-
wide in silico cis-regulatory analysis that yielded
the CCc/tC motif. The MatrixREDUCE algorithm
was used to discover a nucleotide sequence motif
(in the form of a weight matrix) whose occurrences
in the 30UTR optimally predict p53-dependent
changes in steady-state mRNA expression 72 hr
after doxorubicin treatment.
(B) Motif occurrences in a 400 bp window imme-
diately upstream of the polyadenylation site are
significantly more predictive of the expression
changes than those downstream, suggesting that
the C-rich motifs represent the specificity of an
RNA-binding factor.
(C) HepG2 cells were treated either with ctrl or
Nup98#1 and Nup98#2 siRNA for 72 hr, and
300 nM (CPT) was added for the final 24 hr before
RNA extraction. 14-3-3smRNA was measured by
qRT-PCR. The ctrl siRNA and no CPT condition
was taken as 1. Data are presented as mean ± SD
of two independent experiments.
(D) RNA-IP experiment in HepG2 cells was per-
formed as in Figure 4A. Primer pairs specific for
different regions of 14-3-3s mRNA were used to
localize the potential regions of interaction with
Nup98. The rectangle represents the single 14-3-
3s exon, and the shaded area indicates the 30UTR.
The numbers indicate the position of each ampli-
con within the 14-3-3s gene locus. Data are pre-
sented as mean ± SD.
factor. The C-rich motif is also robust in
the sense that using other differential
steady-state expression data yields
consistent results. First, occurrences in
the 30UTR correlated significantly with
the difference in mRNA expression 72 hr
versus 48 hr after doxorubicin treatment
in p53-active cells (p = 3 3 1049) (Chau
et al., 2009). Second, they correlate with the difference in
mRNA expression 24 hr after Nutlin versus mock treatment
(p = 3 3 1032) (Goldstein et al., 2012).
The above results suggested that the C-rich motif mediates
a posttranscriptional and p53-dependent regulatory signal. We
used this motif to rank a list of 120 bona fide p53 target
genes (Riley et al., 2008) in terms of the total motif score in
their 30UTR (Table S2). We found that 14-3-3s scored the
highest and p21 ranked sixth. Indeed, in HepG2 cells,
Nup98 was required for full 14-3-3s expression (Figure 5C).
Furthermore, as with p21, we were able to coimmunoprecipi-
tate the 14-3-3s mRNA 30UTR with Nup98 (Figure 5D). The
finding that the highest-scoring candidate behaved similarly
to p21 supports the efficacy of this in silico screen, and
increases further the likelihood that Nup98 interaction with
30UTR regions of select p53 target genes contributes to their
stability.
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Nup98 Depletion Increases Camptothecin-Induced Cell
Death and Decreases Senescence Mediated by Nutlin
Although p21 is well known for its ability to regulate the cell cycle,
it also functions to inhibit cell death under stress conditions
(reviewed in Abbas and Dutta, 2009). Decreased p21 levels
observed after Nup98 knockdown may sensitize cells to drug-
induced apoptosis. To test this, HepG2 cells were treated
with siRNAs specific for Nup98 or p21 and harvested after
24 hr treatment with CPT followed by FACS analysis. While
there were no major changes in cell-cycle distribution, there
was an increase in cell death after Nup98 knockdown (Fig-
ure 6A). This corresponded well with the results of p21 siRNA-
mediated knockdown, where we observed an even higher
percentage of sub-G1 cells, possibly due to an even greater
reduction of p21 protein levels (Figure 6B). Decreased p21




Figure 6. Nup98 Depletion Increases Camp-
tothecin-Induced Cell Death and Decreases
Nutlin-Induced Senescence
(A) Nup98 knockdown sensitizes cells to CPT-
induced apoptosis. (Upper panels) FACS analysis
was performed with propidium iodide-stained
samples of HepG2 cells following transfection with
control (ctrl) or Nup98 (98#1 and 98#2) siRNAs and
drug treatment as described in Figure 1A. Data
were analyzed using the ModFit program. (Lower
left panel) Bar diagram shows relative percentage
of subG1 cells taken as a measurement of cell
death for each indicated condition. Data are pre-
sented as mean ± SD derived from two indepen-
dent experiments. (Lower right panel) Protein
levels in HepG2 cells treated as above were
analyzed by immunoblotting with indicated anti-
bodies.
(B) p21 knockdown recapitulates the effects of
Nup98 knockdown in CPT-treated cells. (Left
panel) FACS analysis was performed in HepG2
cells as described in (A) following transfection with
p21 siRNA (21#1 and 21#2) and drug treatment.
Bar diagram shows relative percentage (%) of
subG1 cells as a measurement of cell death for
each indicated condition. Data are presented as
mean ± SD derived from two independent exper-
iments. (Right panel) Protein levels in cells treated
as above detected by western blotting with indi-
cated antibodies.
(C) Nup98 knockdown decreases Nutlin-induced
senescence. Sk-Hep1 cells were treated either
with ctrl or Nup98#1 and Nup98#2 siRNA for 24 hr,
and Nutlin-3 (10 mM) was added as indicated
5 days prior to staining senescence-associated
b-galactosidase (SA-b-Gal). Shown are represen-
tative images of cells with SA-b-Gal staining for the
indicated conditions.
a contributing factor to the increased
cell death that occurs upon Nup98
knockdown.
Cellular senescence is another impor-
tant p53-mediated and p21-related
cellular outcome (Abbas and Dutta,
2009). After 5 days of Nutlin treatment of control siRNA-trans-
fected Sk-Hep1 cells, there was a strong increase of senes-
cence-associated b-galactosidase activity (SA-b-Gal) (43% ±
15% positive cells) compared to corresponding DMSO-treated
controls (<0.01% positive cells), which were significantly dimin-
ished when Nup98 levels were reduced (12% ± 9% and 16% ±
8%, in cells containing Nup98 siRNA #1 and siRNA#2, respec-
tively) (Figure 6C). Thus Nup98 offers partial protection from
DNA damage-mediated apoptosis, but cells require Nup98 to
undergo senescence mediated by p53.
Nup98 Expression Is Downregulated in an HCC Mouse
Model and in Human Patients with HCC
Other than the H1299 lung carcinoma-derived cell line engi-
neered to inducibly express ectopic p21 (H24 p21 cells), the
only cell lines in which Nup98 reduction repeatedly produced
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a strong effect on p21 levels were derived from liver cancers
(data not shown), suggesting that Nup98 levels may be altered
in hepatocellular carcinoma (HCC). We tested this possibility in
both a murine model of HCC and in tissues from HCC patients
(Figure 7). The multidrug resistance 2 (MDR-2) knockout mouse
is a model for inflammation-associated HCC development and
resembles the human clinical progression of the disease (Mauad
et al., 1994). We analyzed Nup98 expression in tumorous (T) and
nontumorous (NT) mouse liver tissue by immunohistochemistry
(IHC). Strong Nup98 IHC staining was detected at the nuclear
membrane and within the nucleus in hepatocytes (black arrows)
and in the sinusoidal cells (blue arrows) of NT liver tissue (Fig-
ure 7A, lower left panel). Strikingly, while the sinusoidal cells
and the infiltrating inflammatory cells (blue arrows) retained
strong Nup98 IHC staining in the T-liver tissue (Figure 7A, lower
right panel), there was a significant decrease in Nup98 immuno-
reactivity (p < 0.01) of hepatocellular tumor cells (black arrows)
compared to NT tissue (Figure 7A, lower right panel, and see
semiquantitative analysis of hepatocellular Nup98 staining inten-
sity in NT tissue and T tissue of MDR-2/ mice in Figure 7B).
Thus, Nup98 is substantially downregulated in murine HCC
compared to adjacent nontumorous tissue.
To gain insight into a possible role for Nup98 in human HCC,
we analyzed Nup98 mRNA expression in a cohort of HCC
patients comparing HCC tissue samples with NT liver tissue or
with primary hepatocytes (Figure 7C). Nup98 expression was
significantly reduced (by a factor of R2 compared to controls)
in 25% of the cases (7/27) and was overexpressed in only 1
out of 27 cases (byR2-fold compared to control levels). More-
over, Nup98 and p21 expression were associated with a correla-
tion coefficient of r = 0.56 (p < 0.01) (Figure 7D), suggesting that
Nup98-dependent regulation of p21may also be relevant in vivo.
It is noteworthy that in a second cohort of HCCpatients we found
a similar expression pattern with downregulation of Nup98
expression compared to nontumorous liver in 39% (13/33) and
upregulation of Nup98 expression in 12% (4/33) of the cases
based on the same thresholds (Figure S4). Again we found
a correlation between Nup98 and p21 expression (r = 0.40; p <
0.05, data not shown). Taken together, these data suggest that
Nup98-dependent regulation of p21 is likely to be generalizable
to a significant fraction of human HCCs.
DISCUSSION
An RNAi screen revealed that interference with the NPC causes
pleiotropic effects on p53 target gene induction. While ablation
of a subset of Nups such as Nup98, TPR (translocated promoter
region), and Nup93 selectively reduced p21 mRNA accumula-
tion, Aladin knockdown selectively increased p21 mRNA induc-
tion. Despite the limitations of this screen (e.g., differences in
A B
DC
Figure 7. Nup98 Expression Is Downregu-
lated in Hepatocellular Carcinomas in
MDR-2–/– Mice and in Patients with HCC
(A and B) Lowered hepatocellular Nup98 immu-
noreactivity in murine tumor tissue compared to
nontumorous tissue. (A) Corresponding represen-
tative liver sections ofMDR-2/mice (15 months)
either stained with H&E (upper left and upper right
panel) or immunohistochemically stained with
a polyclonal Nup98 antibody (lower left and lower
right panel). Nontumorous (NT) and tumorous (T)
liver tissue are shown in the left and right columns,
respectively. Black arrows indicate nuclei of
hepatocytes and hepatocellular tumor cells and
blue arrows indicate nuclei of sinusoidal cells and
inflammatory cells. Scale bar represents 100 mm.
(B) Diagram shows median values of semi-
quantiative hepatocellular Nup98 immunohisto-
chemical staining intensities of nontumorous (NT)
and tumorous (T) liver tissue samples of individual
MDR-2/ mice. Statistical significance was
determined from nonparametric testing (Mann-
Whitney U test, **p < 0.01).
(C) Nup98 expression is downregulated in human
hepatocellular carcinoma. The relative Nup98
mRNA expression in 27 human hepatocellular
carcinoma (HCC) tissue samples (black bars) was
assessed by qRT-PCR and compared to the
similarly assessed averaged expression (hori-
zontal line) of two nontumorous (NT) liver tissues
normalized to 1 (white bars). Red dotted lines
indicate thresholds of 2-fold higher or lower
expression than the averaged expression in nontumorous liver tissue. Relative expression in primary hepatocytes (PHH) is also shown (gray bar). 18 s-rRNA was
used as a housekeeping gene for internal normalization. Data are presented as mean ± SD.
(D) Nup98 and p21 expression are correlated in human hepatocellular carcinoma (HCC). Scatterplot depicts relative Nup98 (x axis) and p21 (y axis) mRNA levels
measured by qRT-PCR in tumors of the same cohort of HCC patients as in (C). Pearson’s correlation coefficient was used as a measure of association.
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knockdown efficiency, secondary structural alterations of the
NPC upon decreased expression of some Nups, etc.) we can
assume that selectively reduced p21 mRNA accumulation
upon Nup98 ablation is not a general phenomenon observed
by depleting any nuclear pore component. Since components
of the NPC modulate the expression of p53 target genes in
different directions, stabilization of p21 mRNA by Nup98 is
unlikely to be the only mechanism that can be envisioned (others
include transcriptional regulation, altered protein import/export,
etc.). This adds another layer of complexity to p53 target gene
selection in general and to p21 expression in particular.
Nup98 prevents p21 mRNA degradation by the exosome.
This might be related to a role for Nup98 in p21 mRNA export.
In fact, a yeast Nup116 deletionmutant exhibits anmRNA export
block and accumulation of nuclear mRNAs (Das et al., 2003). Yet
in our single-molecule FISH analysis of p21 mRNA, Nup98
knockdown does not lead to increased accumulation of nuclear
p21 mRNA. Thus, if knockdown of human Nup98 causes a p21
mRNA export block, this must be tightly coupled to degradation
of p21 mRNA transcripts, most likely by the nuclear exosome.
Indeed, in the Nup116 delta yeast strain, accumulation of nuclear
mRNAs is followed by rapid degradation that can be prevented
by disruption of the nuclear exosome (Das et al., 2003). In our
system, an analogous immediate degradation of unexported
p21 mRNA could account for the observed lowered levels of
both nuclear and cytoplasmic p21 mRNA. A second scenario
can be imagined in which, in addition to its putative effects on
p21 mRNA nuclear stability, Nup98 might independently regu-
late the accumulation of cytoplasmic p21 mRNA. Given the
association of Nup98 with the 30UTR of p21 mRNA, it may recruit
additional factors that stabilize p21 mRNA in the cytoplasm.
In either case, the exosome likely recognizes and degrades
p21mRNA upon Nup98 depletion as a process of mRNA surveil-
lance related either to impaired export or to defects in RNA-
protein complex formation in the 30UTR region. Supporting this
hypothesis, the exosome has been documented to participate
in control mechanisms that remove aberrant RNAs in the nucleus
and in the cytoplasm (reviewed in Houseley et al., 2006). Future
studies will hopefully elucidate the particular stability defect and
subsequent degradation of p21mRNA that occurs in the
absence of Nup98.
Bioinformatics analysis identified a C-rich motif that correlates
with the stabilizing effect of Nup98 on p21 mRNA and 14-3-3s
mRNA. It will be important eventually to determine which other
p53 targets that have high (or low) scores with the C-rich motif
are similarly regulated (or not) by Nup98. Particularly relevant
to our studies, RNA binding proteins including different members
of the poly-C binding protein family (PCBP1, PCBP2, and
PCBP4, the latter being a p53 target gene) are implicated in
p21 mRNA destabilization via binding to its 30UTR (Scoumanne
et al., 2010; Waggoner et al., 2009; Zhu and Chen, 2000). Based
on the observation that basal p21 mRNA levels are not signifi-
cantly affected by Nup98 depletion, perhaps Nup98 competes
with a p21 mRNA destabilizing factor that is induced by p53,
such as MCG-10 (poly C binding protein 4) (Zhu and Chen,
2000). Alternatively, p21 protein induction may repress expres-
sion of a stabilizing factor of its own mRNA. Under basal condi-
tions, this factor could compensate for the loss of Nup98.
However, under induced conditions (e.g., CPT), this factor would
be unavailable to stabilize p21 mRNA due to its depletion via
p21-dependent mechanisms. Finally, posttranslational modifi-
cations of Nup98 upon p53/p21 activation may be required for
the stabilizing effect on the p21mRNA transcript. Exploring
aspects of these proposed scenarios will be of considerable
interest for further studies.
Data from the murine HCC model, combined with data from
both cohorts of HCC patients (Figure 7 and Figure S4), suggest
that itmaybeadvantageous for tumors to loseNup98expression,
i.e., that Nup98 acts under certain circumstances as a tumor
suppressor in hepatocarcinogenesis. In line with this is the
observation that p53-mediated induction of senescence, an
important liver tumor-suppressive response (Xue et al., 2007), is
impaireduponNup98depletion (Figure6).However,morestudies
including mouse models with a liver-specific conditional Nup98
knockout are required to draw firm conclusions about tumor-
suppressive functions of Nup98 that might be context and stress
specific. In fact, sinceup to 12%ofHCCpatients showedoverex-
pression of Nup98, it is quite possible that Nup98may play a dual
role in cancer formation as does p21 or, even more intriguingly,
through p21. The latter could be supported by the correlation of
Nup98 and p21 expression in both patient data sets. We expect
that future studies will elucidate the specific circumstances
under which Nup98 may act as barrier to cancer formation.
EXPERIMENTAL PROCEDURES
Cell Culture and Drug Treatment
HepG2 cells were maintained in RPMI medium supplemented with 10% fetal
bovine serum (FBS). Hep3B cells and the derivatives Hep3B-4Bv (expressing
the temperature-sensitive p53val135 mutation) were kindly provided by
M. Oren (Friedman et al., 1997) and maintained in MEM with 10% FBS (and
1 mg/mL puromycin for Hep3B-4Bv). H1299 cells and their derivative tet-off
H24-p21-inducible cell line were previously described (Niculescu et al.,
1998) and were maintained in DME medium with 10% FBS and tetracycline
(5 mg/ml). p21 expression was induced by removing tetracycline 48 hr
before harvesting the cells. H1299 PUMA-inducible cells (tet-on) were gener-
ously provided by K. Vousden (Nakano and Vousden, 2001) and grown in
DME with 10% FBS. PUMA expression was induced by adding Doxycycline
(2 mg/mL) 24 hr before harvesting. CPT, Nutlin-3a, and Actinomycin D (Sigma)
were used as indicated.
Transfections and Plasmids
siRNA transfection assays were performed with DharmaFECT 1 (Dharmacon)
or Oligofectamine (Invitrogen). siRNA duplexes, designed and synthesized by
QIAGEN, were used individually at 50 nM (sequences are listed in Table S3).
The QIAGEN All-Stars duplex was used as the negative control siRNA for all
knockdown experiments besides the p21 mRNA half-life experiment, where
Luc siRNA was used. HA-Nup98 was generously provided by Dr. N.R. Yaseen
(Washington University School of Medicine, USA). GFP-Nup98 full length,
GFP-Nup98 C terminus (506–920), GFP-Nup98 GLFG+C terminus (221–
920), and GFP-Nup98 GLFG(C)+C terminus (362–920) were as described
(Griffis et al., 2004). HA-Nup96 was kindly provided by Dr. B. Fontoura (UT
Southwestern Medical Center, USA). cDNAs encoding p21 full length (FL),
PUMA full length (Pu FL) including the respective 50UTRs and 30UTRs, and
p21 lacking the 30UTR were amplified by PCR with a Platinum Pfx DNA poly-
merase (Invitrogen) using cDNA from HepG2 cells as template. The resulting
p21 FL and p21 delta 30UTR cDNAs were then cloned into a pcDNA3.1 vector
(Invitrogen). The Pu/p21 hybrid construct was generated by amplifying the
PUMA CDS (including the 50UTR) and p21 30UTR from the respective FL
constructs, that were sequentially cloned into a pcDNA3.1 vector (Invitrogen).
The Luc/p21 30UTR and Luc control were as described (Giles et al., 2003).
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Transient plasmid transfections were done with Lipofectamin2000 (Invitrogen)
according to the manufacturer’s protocol.
Quantitative Reverse Transcription-Polymerase Chain Reaction
RNA was isolated from cells with the QIAGEN RNeasy Mini kit and was DNase
treated and reverse transcribed using the QIAGEN Quantitect reverse tran-
scription kit. Samples were analyzed on an ABI 7300 real-time PCR instrument
with default settings using the DDCT method. Expression levels were normal-
ized to those of RPL32 or 18 s RNA (patient samples). Primers used were
designed with Primer Express (Applied Biosystems), and sequences are listed
in Table S4.
Immunoblots and Antibodies
Cells were harvested and subjected to immunoblotting as previously
described (Ohkubo et al., 2006). Commercial antibodies used in the study
are listed in Table S5. Nup98 rabbit polyclonal antibody was kindly provided
by Dr. G. Blobel (Rockefeller University, USA), and Nup96 rabbit polyclonal
antibody was a kind gift from Dr. Joseph Glavy (Stevens Institute of Tech-
nology, USA). Signal detection was performed by the using the Odyssey
Infrared Imaging System (LI-COR).
Immunofluorescent Staining
HepG2 and H24 p21 cells were grown on coverslips and treated with drugs as
indicated. Immunofluorescent staining was performed as previously described
(Karni-Schmidt et al., 2007). Nup98 (C-5; Santa-Cruz) was used as primary
antibody followed by Alexa Fluor 488 rabbit anti-mouse secondary antibody
(Molecular Probes, Eugene, OR). Images were analyzed by confocal laser
scanning microscopy (Olympus model 1381) using Fluoview software (Canter
Valley, PA).
Fluorescence-Activated Cell Sorting
Cells were processed with slight modifications as described before (Ohkubo
et al., 2006). Cell-cycle stages were analyzed by using the ModFit LT version
3.0 program, and subG1 fractions were analyzed using Cell Quest Pro.
Fluorescence In Situ Hybridization
To detect p21mRNA, 14 oligodeoxynucleotide probes were designed, synthe-
sized, and labeled as previously described (Femino et al., 1998). Each probe
had a length of 50 nt and contained five amino-modified nucleotides (amino-
allyl T). The free amines were chemically coupled to cyanine 5 fluorescent
dye after synthesis. The sequences of probes used to detect p21 mRNA are
available upon request. mRNA-FISH was performed based on a published
protocol (http://www.singerlab.org/protocols). For further information, see
the Supplemental Experimental Procedures.
RNA Immunoprecipitation
RNA-IP was performed using a published protocol (Kaneko andManley, 2005)
with slight modifications. Further information is provided in the Supplemental
Experimental Procedures.
Animals and Immunohistochemical Staining
MDR-2/ animals were described previously (Mauad et al., 1994). Liver tissue
of 15-month-old male MDR-2/ mice was immunostained based on a pub-
lished protocol (Singer et al., 2007) by using a polyclonal Nup98 antibody.
For additional information, see the Supplemental Experimental Procedures.
MDR2/ mice were housed under specific pathogen-free conditions. The
procedures for performing animal experiments were in accordance with the
principles and guidelines of the Arbeitsgemeinschaft der Tierschutzbeauf-
tragten in Baden-Wu¨rttemberg and were approved by the Regierungspra¨si-
dium of Karlsruhe, Germany. Staining intensity of nontumorous and tumorous
tissue was evaluated by a pathologist using a semiquantitative score: 0 = no,
1 = weak, 2 = moderate, 3 = strong, and 4 = very strong staining. The median
score out of up to five high-power fields was calculated.
Patient Data
Total RNA isolation of HCC samples (n = 27 and n = 33) and healthy liver tissues
(n = 2 and n = 5) of both cohorts for semiquantitative real-time PCR was per-
formed using the NucleoSpin RNA II kit according to the manufacturers’
protocol (Macherey-Nagel, Duren, Germany). The study was approved by
the institutional ethics committee of the Medical Faculty at Heidelberg
University.
Motif Discovery
We used the MatrixREDUCE program from the REDUCE software suite (http://
bussemakerlab.org/software/REDUCE) to perform a genomewide fit of a posi-
tion-specific affinity matrix (PSAM) to the logarithm of mRNA expression fold-
differences between wild-type cells and p53 knockdown cells (after 72 hr). For
the sequence associated with each log ratio, we used the March 2006 version
of human 30UTRs from the UCSC genome website (http://genome.ucsc.edu).
Genes with overlapping 30UTRs were filtered out. In the PSAM search,
we considered motif lengths from 1 to 10 and used a p value threshold of
0.001. To rank the p53 target genes, we calculated the total affinity of
the 30UTR using the AffinityProfile program from the REDUCE suite to score
the enrichment of each 30UTR for the discovered C-rich motif. Total relative
affinities were calculated as the sum of PSAM-based predicted affinities in
a sliding window over the length of the 30UTR. We controlled for variation in
30UTR length by dividing the total affinity by the UTR length and used the
resulting affinity density to rank the list of published p53 targets (Riley et al.,
2008).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, five tables, and Supplemental
Experimental Procedures and can be found with this article at http://dx.doi.
org/10.1016/j.molcel.2012.09.020.
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